Novartis Pharmaceuticals Corp.

Form 483

Suffern, New York, United StatesFEI 2416082Issued December 19, 2012

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 2416082.

Observations2

Issue DateDecember 19, 2012

StatusNo Warning Letter

Related Inspections9

Establishment Details

Firm: Novartis Pharmaceuticals Corp.
Location: Suffern, New York, United States
FEI Number: 2416082
Product Type: Drugs
Issue Date: December 19, 2012
Country: United States

Inspection History, 2008 to 2015

NAI3

VAI6

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Novartis Pharmaceuticals Corp. FDA Form 483, Suffern, New York, December 19, 2012